AUPH FY 2023 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$176M+31.0% YoY

Gross Profit

$161M91.9% margin

Operating Income

-$92M-52.2% margin

Net Income

-$78M-44.5% margin

EPS (Diluted)

$-0.54

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$34M

Stock-Based Comp.

$45M

Balance Sheet

Total Assets

$548M

Total Liabilities

$170M

Stockholders' Equity

$378M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$176M	$134M	+31.0%
Gross Profit	$161M	$128M	+25.7%
Operating Income	-$92M	-$111M	+17.7%
Net Income	-$78M	-$108M	+27.9%